Nuclear translocation during the cross-talk between cellular stress, cell cycle and anticancer agents

Current Medicinal Chemistry

Volumn 13, Issue 11, 2006, Pages 1317-1320

  Tiligada, E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Anticancer agents; Cell cycle; Nuclear translocation; Stress response; Yeast

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; 2 METHOXYESTRADIOL; 7 HYDROXYSTAUROSPORINE; ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATASE; ANSAMYCIN DERIVATIVE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; COLCHICINE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GELDANAMYCIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTACYSTIN; LEPTOMYCIN B; MEVINOLIN; MIDOSTAURIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOMYCIN C; PACLITAXEL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN MDM2; PROTEIN P53; RADICICOL; REACTIVE OXYGEN METABOLITE; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CELL COMPARTMENTALIZATION; CELL CYCLE ARREST; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL TRIAL; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC STABILITY; HUMAN; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVIEW; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS; NF-KAPPA B; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; STRESS; TUMOR SUPPRESSOR PROTEIN P53; YEASTS;

EID: 33646528013     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986706776872952     Document Type: Review

References (65)

1. Swanton, C. Lancet Oncol., 2004, 5, 27.
2. Higa, G.M. Exp. Rev. Anticancer Ther., 2004, 4, 61.
3. Kuersten, S.; Ohno, M.; Mattaj, I.W. Trends Cell. Biol., 2001, 11, 497.
4. Kau, T.R.; Silver, P.A. Drug Discov. Today, 2003, 8, 78.
5. Tiligada, E.; Miligkos, V.; Delitheos, A. Curr. Med. Chem. Anticancer Agents, 2002, 2, 553.
6. Hauptmann, S.A. Med. Hypotheses, 2002, 58, 144.
7. Shtil, A.A.; Mandlekar, S.; Yu, R.; Walter, R.J.; Hagen, K.; Tan, T.H.; Roninso, I.B.; Kong, A.N. Oncogene, 1999, 18, 377.
8. Krasilnikov, M.; Ivanov, V.N.; Dong, J.; Ronai, Z. Oncogene, 2003, 22, 4092.
9. Kim, R.D.; Darling, C.E.; Roth, T.P.; Ricciardi, R.; Chari, R.S. J. Surg. Res., 2001, 100, 176.
10. Krejsa, C.M.; Schieven, G.L. Environ. Health Perspect., 1998, 106, Suppl 5, 1179.
11. Stavrinidis, E.; Delitheos, A.; Tiligada, E. Folia Microbiol., 2002, 47, 157.
12. Miligkos, V.; Tiligada, E.; Papamichael, K.; Ypsilantis, E.; Delitheos, A. Folia Microbiol., 2000, 45, 339.
13. Tiligada, E.; Miligkos, V.; Ypsilantis, E.; Papamichael, K.; Delitheos, A. Lett. Appl. Microbiol., 1999, 29, 77.
14. Vovou, I.; Delitheos, A.; Tiligada, E. J. Appl. Microbiol., 2004, 96, 1271.
15. Vovou, I.; Delitheos, A.; Tiligada, E. Br. J. Pharmacol., 2003, 138, 72P.
16. Stein, U.; Jurchott, K.; Walther, W.; Bergmann, S.; Schlag, P.M.; Royer, H.D. J. Biol. Chem., 2001, 276, 28562.
17. Tzatsos, A.; Papavassiliou, A.G. Anticancer Res., 1999, 19, 4353.
18. Sanchez-Prieto, R.; Rojas, J.M.; Taya, Y.; Gutkind, J.S. Cancer Res., 2000, 60, 2464.
19. Wansa, K.D.; Harris, J.M.; Yan, G.; Ordentlich, P.; Muscat, G.E. J. Biol. Chem., 2003, 278, 24776.
20. Ihnat, M.A.; Lariviere, J.P.; Warren, A.J.; La Ronde, N.; Blaxall, J.R.; Pierre, K.M.; Turpie, B.W.; Hamilton, J.W. Clin. Cancer Res., 1997, 3, 1339.
21. Christmann, M.; Kaina, B. J. Biol. Chem., 2000, 275, 36256.
22. Ito, K.; Ozasa, H.; Kojima, N.; Miura, M.; Iwa, T.; Senoo, H.; Horikawa, S. Shock, 2003, 19, 462.
23. Li, T.K.; Liu, L.F. Annu. Rev. Pharmacol. Toxicol., 2001, 41, 53.
24. Benhar, M.; Engelberg, D.; Levitzki, A. EMBO Rep., 2002, 3, 420.
25. Kamio, T.; Toki, T.; Kanezaki, R.; Sasaki, S.; Tandai, S.; Terui, K.; Ikebe, D.; Igarashi, K.; Ito, E. Blood, 2003, 102, 3317.
26. Lai, M.T.; Huang, K.L.; Chang, W.; Lai, Y.K. Cell Signal., 2003, 15, 585.
27. Zhou, Y.; Hileman, E.O.; Plunkett, W.; Keating, M.J.; Huang, P. Blood, 2003, 101, 4098.
28. Bardeleben, R.V.; Dunkern, T.; Kaina, B.; Fritz, G. Int. J. Mol. Med., 2002, 10, 473.
29. Tanaka, M.; Koul, D.; Davies, M.A.; Liebert, M.; Steck, P.A.; Grossman, H.B. Oncogene, 2000, 19, 5406.
30. Borrelli, M.J.; Bernock, L.J.; Landry, J.; Spitz, D.R.; Weber, L.A.; Hickey, E.; Freeman, M.L.; Corry, P.M. Cell Stress Chaperones, 2002, 7, 281.
31. Dastoor, Z.; Dreyer, J. J. Cell Sci., 2000, 113, 2845.
32. Xu, Q.; Hu, Y.; Kleindienst, R.; Wick, G. J. Clin. Invest., 1997, 100, 1089.
33. Kiang, J.G.; Kiang, S.C.; Juang, Y.T.; Tsokos, G.C. Am. J. Physiol. Gastrointest. Liver Physiol., 2002, 282, G415.
34. Mark, P.J.; Ward, B.K.; Kumar, P.; Lahooti, H.; Minchin, R.F.; Ratajczak, T. Cell Stress Chaperones, 2001, 6, 59.
35. Whitesell, L.; Cook, P. Mol. Endocrinol., 1996, 10, 705.
36. Goetz, M.P.; Toft, D.O.; Ames, M.M.; Erlichman, C. Ann. Oncol., 2003, 14, 1169.
37. Harris, N.; MacLean, M.; Hatzianthis, K.; Panaretou, B.; Piper, P.W. Mol. Genet. Genomics., 2001, 265, 258.
38. Pratt, W.B.; Toft, D.O. Endocrine Rev., 1997, 18, 306.
39. Goes, F.S.; Martin, J. Eur. J. Biochem., 2001, 268, 2281.
40. Soga, S.; Shiotsu, Y.; Akinaga, S.; Sharma, S.V. Curr. Cancer Drug Targets, 2003, 3, 359.
41. Workman, P. Curr. Cancer Drug Targets, 2003, 3, 297.
42. Whitesell, L.; Sutphin, P.D.; Pulcini, E.J.; Martinez, J.D.; Cook, P.H. Mol. Cell. Biol., 1998, 18, 1517.
43. Ookawara, T.; Eguchi, H.; Nishimura, M.; Kizaki, T.; Takayama, E.; Saitoh, D.; Ohno, H.; Suzuki, K. Biophys. Res. Commun., 2003, 303, 914.
44. Newlands, E.S.; Rustin, G.J.; Brampton, M.H. Br. J. Cancer, 1996, 74, 648.
45. Vigneri, P.; Wang, J.Y. Nat. Med., 2001, 7, 228.
46. Sperandio, S.; de Belle, I.; Bredesen, DE. Proc. Natl. Acad. Sci. USA, 2000, 97, 14376.
47. Gilloteaux, J.; Jamison, J.M,; Arnold, D.; Ervin, E.; Eckroat, L.; Docherty, J.J.; Neal, D.; Summers, J.L. Scanning, 1998, 20, 564.
48. Yamamoto, Y.; Gaynor, R.B. Curr. Mol. Med., 2001, 1, 287.
49. Karin, M.; Cao, Y.; Greten, F.R.; Li, Z-W. Nat. Rev. Cancer, 2002, 2, 301.
50. Huang, T.T.; Wuerzberger-Davis, S.M.; Wu, Z.H.; Miyamoto, S. Cell, 2003, 115, 565.
51. Goto, D.; Izumi, H.; Ono, M.; Okamoto, T.; Kohno, K.; Kuwano, M. Angiogenesis, 1998, 2, 345.
52. Ariga, A.; Namekawa, J.; Matsumoto, N.; Inoue, J.; Umezawa, K. J. Biol. Chem., 2002, 277, 24625.
53. Chaicharoenpong, C.; Kato, K.; Umezawa, K. Bioorg. Med. Chem., 2002, 10, 3933.
54. Horiguchi, Y.; Kuroda, K.; Nakashima, J.; Murai, M.; Umezawa, K. Exp. Rev. Anticancer Ther., 2003, 3, 793.
55. Mayo, L.D.; Dixon, J.E.; Durden, D.L.; Tonks, N.K.; Donner, D.B. J. Biol. Chem., 2002, 277, 5484.
56. Wang, X.; Taplick, J.; Geva, N.; Oren, M. FEBS Lett., 2004, 561, 195.
57. Sabbatini, P.; McCormick, F. J. Biol. Chem., 1999, 274, 24263.
58. Mayo, L.D.; Donner, D.B. Trends Biochem. Sci., 2002, 27, 462.
59. Tanaka, M.; Koul, D.; Davies, M.A.; Liebert, M.; Steck, P.A.; Grossman, H.B. Oncogene, 2000, 19, 5406.
60. Sausville, E.A.; Arbuck, S.G.; Messmann, R.; Headlee, D.; Bauer, K.S.; Lush, R.M.; Murgo, A.; Figg, W.D.; Lahusen, T.; Jaken, S.; Jing, X.; Roberge, M.; Fuse, E.; Kuwabara, T.; Senderowicz, A.M. J. Clin. Oncol., 2001, 19, 2319.
61. Monnerat. C.; Henriksson, R.; Le Chevalier, T.; Novello, S.; Berthaud, P.; Faivre, S.; Raymond, E. Ann. Oncol., 2004, 15, 316.
62. Reed, S.I. Nat. Rev. Mol. Cell Biol., 2003, 4, 855.
63. Hu, W.; Wu, W.; Verschraegen, C.F.; Chen, L.; Mao, L.; Yeung, S.C.; Kudelka, A.P.; Freedman, R.S.; Kavanagh, J.J. Proteomics, 2003, 3, 1904.
64. Sun, Y. Cancer Biol. Ther., 2003, 2, 623.
65. Mazieres, J.; Pradines, A.; Favre, G. Cancer Lett., 2004, 206, 159.